Biotech Values

[turtlepower]

ALTH and ADAM F - Adam has been a staunch supporter of ALTH. I wonder what he will write about ALTH raising money since he has been claiming that it is a likely candidate to partner or even be bought out. In the past he has been skeptical about companies that were unable to find a partner.

Allos Therapeutics Announces Proposed Public Offering of Common Stock

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (Nasdaq: ALTH - News) today announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Allos Therapeutics also intends to grant the underwriters a 30-day option to purchase up to an aggregate of 1,650,000 additional primary shares of common stock to cover over-allotments, if any. All of the shares in the offering are to be sold by Allos Therapeutics, with proceeds to be used to support the commercialization of FOLOTYN™ (pralatrexate injection), preclinical research and clinical development of FOLOTYN, and general corporate purposes. J.P. Morgan Securities Inc. and Citigroup Global Markets, Inc. are acting as joint book-running managers of the proposed offering. Leerink Swann LLC is acting as co-lead manager of the offering. JMP Securities LLC is acting as co-manager of the offering.

http://finance.yahoo.com/news/Allos-Therapeutics-Announces-bw-3005021453.html?x=0&.v=1